NYSE:INSP - Inspire Medical Systems Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $288.00
  • Forecasted Upside: 42.86 %
  • Number of Analysts: 7
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$201.59
▲ +0.58 (0.29%)

This chart shows the closing price for INSP by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Inspire Medical Systems Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for INSP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for INSP

Analyst Price Target is $288.00
▲ +42.86% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Inspire Medical Systems in the last 3 months. The average price target is $288.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 42.86% upside from the last price of $201.59.

This chart shows the closing price for INSP for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 7 investment analysts is to buy stock in Inspire Medical Systems. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/12/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/12/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/11/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/9/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/7/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/7/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/6/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/6/2022

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/10/2022Truist FinancialLower Price TargetBuy$296.00 ➝ $250.00Medium
5/4/2022Piper SandlerBoost Price Target$305.00 ➝ $310.00High
4/12/2022Truist FinancialInitiated CoverageBuy$315.00High
4/5/2022Wolfe ResearchInitiated CoverageMarket Perform$270.00Medium
3/2/2022Bank of AmericaInitiated CoverageBuy ➝ BuyHigh
2/9/2022SVB LeerinkBoost Price TargetOutperform$270.00 ➝ $273.00High
11/3/2021Lake Street CapitalBoost Price TargetBuy$260.00 ➝ $320.00Medium
11/3/2021Wells Fargo & CompanyBoost Price TargetOverweight$250.00 ➝ $305.00Medium
11/3/2021SVB LeerinkBoost Price TargetOutperform$300.00 ➝ $325.00Medium
11/3/2021Piper SandlerBoost Price TargetPositive ➝ Overweight$238.00 ➝ $305.00Medium
10/22/2021SVB LeerinkReiterated RatingOutperformHigh
9/24/2021SVB LeerinkBoost Price TargetOutperform$265.00 ➝ $300.00Low
8/4/2021SVB LeerinkLower Price TargetOutperform$275.00 ➝ $265.00High
8/4/2021Piper SandlerBoost Price TargetOverweight$215.00 ➝ $238.00High
7/20/2021Piper SandlerLower Price TargetOverweight$235.00 ➝ $215.00High
7/14/2021Piper SandlerLower Price TargetOverweight ➝ Overweight$255.00 ➝ $235.00High
6/23/2021SVB LeerinkReiterated RatingBuyMedium
5/25/2021SVB LeerinkReiterated RatingBuyMedium
5/5/2021Lake Street CapitalBoost Price TargetBuy$250.00 ➝ $260.00High
5/5/2021Piper SandlerBoost Price TargetPositive ➝ Overweight$252.00 ➝ $255.00High
4/25/2021Robert W. BairdReiterated RatingBuyHigh
2/24/2021Piper SandlerBoost Price TargetOverweight$210.00 ➝ $252.00Medium
2/24/2021Lake Street CapitalBoost Price TargetBuy$215.00 ➝ $250.00Low
2/24/2021SVB LeerinkBoost Price TargetOutperform$225.00 ➝ $275.00High
1/7/2021Lake Street CapitalBoost Price TargetBuy$150.00 ➝ $215.00Low
1/4/2021Bank of AmericaDowngradeBuy ➝ NeutralN/A
12/15/2020The Goldman Sachs GroupDowngradeBuy ➝ Neutral$162.00 ➝ $209.00Low
12/3/2020Piper SandlerBoost Price TargetOverweight$147.00 ➝ $210.00Medium
11/3/2020Wells Fargo & CompanyBoost Price TargetOverweight$135.00 ➝ $140.00High
11/3/2020SVB LeerinkBoost Price TargetOutperform$150.00 ➝ $170.00High
11/3/2020Robert W. BairdBoost Price TargetOutperform$130.00 ➝ $160.00High
11/3/2020Bank of AmericaUpgradeNeutral ➝ Buy$125.00 ➝ $155.00High
11/3/2020Piper SandlerBoost Price TargetOverweight$137.00 ➝ $147.00High
11/3/2020OppenheimerUpgradeUnderperform ➝ Market PerformHigh
9/22/2020JPMorgan Chase & Co.Initiated CoverageOverweight$148.00High
9/18/2020Piper SandlerBoost Price TargetPositive ➝ Overweight$116.00 ➝ $137.00High
9/10/2020Wells Fargo & CompanyBoost Price TargetOverweight$125.00 ➝ $135.00Medium
9/9/2020SVB LeerinkBoost Price TargetPositive ➝ Outperform$120.00 ➝ $150.00High
9/1/2020Robert W. BairdInitiated CoverageOutperform$130.00Low
8/21/2020Stifel NicolausBoost Price Target$110.00 ➝ $125.00Low
8/6/2020Wells Fargo & CompanyBoost Price TargetPositive ➝ Overweight$115.00 ➝ $125.00Medium
8/6/2020Bank of AmericaDowngradeBuy ➝ Neutral$115.00High
8/5/2020Piper SandlerBoost Price Target$98.00 ➝ $111.00Low
8/5/2020SVB LeerinkBoost Price TargetOutperform$110.00 ➝ $120.00High
8/5/2020Lake Street CapitalBoost Price TargetBuy$100.00 ➝ $130.00High
8/5/2020OppenheimerReiterated RatingSell$42.00 ➝ $50.00High
7/15/2020The Goldman Sachs GroupInitiated CoverageBuy$148.00High
6/29/2020SVB LeerinkBoost Price TargetOutperform$85.00 ➝ $110.00Low
6/18/2020Piper SandlerBoost Price TargetOverweight$81.00 ➝ $98.00Medium
5/26/2020Wells Fargo & CompanyBoost Price TargetOverweight$81.00 ➝ $95.00High
5/18/2020Lake Street CapitalInitiated CoverageBuy$90.00High
5/6/2020GuggenheimBoost Price TargetBuy$80.00 ➝ $90.00High
5/6/2020OppenheimerInitiated CoverageSell$42.00High
4/28/2020Bank of AmericaUpgradeNeutral ➝ Buy$90.00High
4/19/2020Piper SandlerInitiated CoverageOverweight$74.00Medium
4/15/2020Stifel NicolausBoost Price TargetBuy$88.00 ➝ $95.00Low
4/9/2020Piper SandlerInitiated CoverageOverweight$74.00High
4/2/2020OppenheimerLower Price Target$50.00 ➝ $42.00Medium
2/26/2020Bank of AmericaBoost Price TargetNeutral$75.00 ➝ $85.00High
2/26/2020Stifel NicolausBoost Price TargetBuy$82.00 ➝ $88.00High
2/26/2020SVB LeerinkBoost Price TargetOutperform$75.00 ➝ $97.00High
2/26/2020Wells Fargo & CompanyBoost Price TargetOverweight$90.00 ➝ $93.00High
1/27/2020OppenheimerInitiated CoverageUnderperform$50.00High
1/16/2020Wells Fargo & CompanyBoost Price TargetOverweight$70.00 ➝ $90.00High
11/6/2019Berenberg BankUpgradeSell ➝ Hold$46.00 ➝ $51.00High
9/27/2019Dougherty & CoSet Price TargetBuy$78.00High
7/8/2019Bank of AmericaReiterated RatingPositive ➝ Neutral$65.00 ➝ $75.00Low
2/5/2019Dougherty & CoInitiated CoverageBuy ➝ Buy$64.00High
11/28/2018Berenberg BankInitiated CoverageSell ➝ Sell$31.00High
10/29/2018SVB LeerinkInitiated CoverageOutperform ➝ Outperform$57.00High
5/29/2018Wells Fargo & CompanyInitiated CoverageOutperform$38.00High
5/29/2018Bank of AmericaInitiated CoverageNeutral$36.00High
5/29/2018GuggenheimInitiated CoverageBuy$40.00High
5/29/2018The Goldman Sachs GroupInitiated CoverageNeutral$25.00High
5/29/2018Stifel NicolausInitiated CoverageBuy$42.00High
(Data available from 7/7/2017 forward)

News Sentiment Rating

1.12 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/9/2021
  • 10 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/8/2022
  • 8 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/7/2022
  • 3 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/9/2022
  • 6 very positive mentions
  • 0 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
4/8/2022
  • 14 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
5/8/2022
  • 7 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/7/2022
  • 7 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/7/2022

Current Sentiment

  • 7 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Inspire Medical Systems logo
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Read More

Today's Range

Now: $201.59
Low: $198.77
High: $206.77

50 Day Range

MA: $180.87
Low: $147.53
High: $216.48

52 Week Range

Now: $201.59
Low: $142.74
High: $286.29

Volume

193,900 shs

Average Volume

269,729 shs

Market Capitalization

$5.56 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.57

Frequently Asked Questions

What sell-side analysts currently cover shares of Inspire Medical Systems?

The following Wall Street sell-side analysts have issued research reports on Inspire Medical Systems in the last twelve months: Bank of America Co., Lake Street Capital, Piper Sandler, SVB Leerink LLC, TheStreet, Truist Financial Co., Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for INSP.

What is the current price target for Inspire Medical Systems?

0 Wall Street analysts have set twelve-month price targets for Inspire Medical Systems in the last year. Their average twelve-month price target is $288.00, suggesting a possible upside of 42.9%.
View the latest price targets for INSP.

What is the current consensus analyst rating for Inspire Medical Systems?

Inspire Medical Systems currently has 1 hold rating and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe INSP will outperform the market and that investors should add to their positions of Inspire Medical Systems.
View the latest ratings for INSP.

How do I contact Inspire Medical Systems' investor relations team?

Inspire Medical Systems' physical mailing address is 5500 WAYZATA BLVD SUITE 1600, GOLDEN VALLEY MN, 55416. The company's listed phone number is (844) 672-4357 and its investor relations email address is [email protected] The official website for Inspire Medical Systems is www.inspiresleep.com. Learn More about contacing Inspire Medical Systems investor relations.